TNF-α and IFN-γ reverse IL-4 inhibition of lymphokine-activated killer cell function
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 128 (2) , 450-461
- https://doi.org/10.1016/0008-8749(90)90040-x
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Induction of endogenous cytokine-mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients.The Journal of Immunology, 1989
- The inhibitory effect of human interferon α on the generation of lymphokine-activated killer activityCancer Immunology, Immunotherapy, 1989
- Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.Proceedings of the National Academy of Sciences, 1988
- Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes.The Journal of Experimental Medicine, 1988
- Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).The Journal of Experimental Medicine, 1987
- T-cell and mast cell lines respond to B-cell stimulatory factor 1.Proceedings of the National Academy of Sciences, 1986
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferonNature, 1985
- Identification of a T cell-derived b cell growth factor distinct from interleukin 2.The Journal of Experimental Medicine, 1982
- Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activityJournal of Clinical Immunology, 1981